These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 32386438)

  • 1. 'Toxic erythema' and eosinophilia associated with tocilizumab therapy in a COVID-19 patient.
    Sernicola A; Carnicelli G; Di Fraia M; Chello C; Furlan C; Muharremi R; Paolino G; Grieco T
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e368-e370. PubMed ID: 32386438
    [No Abstract]   [Full Text] [Related]  

  • 2. SARS-CoV-2 asymptomatic infection in a patient under treatment with dupilumab.
    Caroppo F; Biolo G; Belloni Fortina A
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e368. PubMed ID: 32386431
    [No Abstract]   [Full Text] [Related]  

  • 3. Improvement of SARS-CoV-2 symptoms following Guselkumab injection in a psoriatic patient.
    Benhadou F; Del Marmol V
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e363-e364. PubMed ID: 32379925
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety of dupilumab in severe atopic dermatitis and infection of Covid-19: two case reports.
    Ferrucci S; Romagnuolo M; Angileri L; Berti E; Tavecchio S
    J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):e303-e304. PubMed ID: 32330323
    [No Abstract]   [Full Text] [Related]  

  • 5. Atypical erythema multiforme palmar plaques lesions due to Sars-Cov-2.
    Janah H; Zinebi A; Elbenaye J
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e373-e375. PubMed ID: 32386446
    [No Abstract]   [Full Text] [Related]  

  • 6. Two cases of skin manifestations prior to the onset of COVID-19 respiratory symptoms.
    Altayeb A; Cordaro A; Caesar J; Vyas J; Ingram J
    Int J Dermatol; 2020 Dec; 59(12):1541-1542. PubMed ID: 33084036
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD.
    Mihai C; Dobrota R; Schröder M; Garaiman A; Jordan S; Becker MO; Maurer B; Distler O
    Ann Rheum Dis; 2020 May; 79(5):668-669. PubMed ID: 32241792
    [No Abstract]   [Full Text] [Related]  

  • 8. Tocilizumab for Hemophagocytic Syndrome in a Kidney Transplant Recipient With COVID-19.
    Faguer S; Del Bello A; Abravanel F; Nicolau-Travers ML; Kamar N
    Ann Intern Med; 2020 Sep; 173(6):501-503. PubMed ID: 32432518
    [No Abstract]   [Full Text] [Related]  

  • 9. Rapid resolution of cytokine release syndrome and favorable clinical course of severe COVID-19 in a kidney transplant recipient treated with tocilizumab.
    Gautier-Vargas G; Baldacini C; Benotmane I; Keller N; Perrin P; Moulin B; Caillard S
    Kidney Int; 2020 Aug; 98(2):508-509. PubMed ID: 32505467
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral vesicles and acral erythema: report of a cutaneous manifestation of COVID-19.
    Aghazadeh N; Homayouni M; Sartori-Valinotti JC
    Int J Dermatol; 2020 Sep; 59(9):1153-1154. PubMed ID: 32710552
    [No Abstract]   [Full Text] [Related]  

  • 11. Tocilizumab administration in a refractory case of COVID-19.
    Dastan F; Nadji SA; Saffaei A; Tabarsi P
    Int J Antimicrob Agents; 2020 Aug; 56(2):106043. PubMed ID: 32502524
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyper-inflammatory Syndrome in a Child With COVID-19 Treated Successfully With Intravenous Immunoglobulin and Tocilizumab.
    Balasubramanian S; Nagendran TM; Ramachandran B; Ramanan AV
    Indian Pediatr; 2020 Jul; 57(7):681-683. PubMed ID: 32393681
    [No Abstract]   [Full Text] [Related]  

  • 13. Tocilizumab in the treatment of a critical COVID-19 patient: a case report.
    Wang L; Peng X; Wang ZH; Cai J; Zhou FC
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5783-5787. PubMed ID: 32495916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diabetic lung: An easy target for SARS-CoV-2?
    Caruso I; Giorgino F
    Diabetes Metab Res Rev; 2020 Nov; 36(8):e3346. PubMed ID: 32426928
    [No Abstract]   [Full Text] [Related]  

  • 15. Symmetric cutaneous vasculitis in COVID-19 pneumonia.
    Castelnovo L; Capelli F; Tamburello A; Faggioli PM; Mazzone A
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e362-e363. PubMed ID: 32378747
    [No Abstract]   [Full Text] [Related]  

  • 16. Rapid and severe Covid-19 pneumonia with severe acute chest syndrome in a sickle cell patient successfully treated with tocilizumab.
    De Luna G; Habibi A; Deux JF; Colard M; Pham Hung d'Alexandry d'Orengiani AL; Schlemmer F; Joher N; Kassasseya C; Pawlotsky JM; Ourghanlian C; Michel M; Mekontso-Dessap A; Bartolucci P
    Am J Hematol; 2020 Jul; 95(7):876-878. PubMed ID: 32282956
    [No Abstract]   [Full Text] [Related]  

  • 17. Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report.
    Michot JM; Albiges L; Chaput N; Saada V; Pommeret F; Griscelli F; Balleyguier C; Besse B; Marabelle A; Netzer F; Merad M; Robert C; Barlesi F; Gachot B; Stoclin A
    Ann Oncol; 2020 Jul; 31(7):961-964. PubMed ID: 32247642
    [No Abstract]   [Full Text] [Related]  

  • 18. Are erythema multiforme and urticaria related to a better outcome of COVID-19?
    Dastoli S; Bennardo L; Patruno C; Nisticò SP
    Dermatol Ther; 2020 Jul; 33(4):e13681. PubMed ID: 32447798
    [No Abstract]   [Full Text] [Related]  

  • 19. SARS-CoV-2 infection in a psoriatic patient treated with IL-17 inhibitor.
    Balestri R; Rech G; Girardelli CR
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e357-e358. PubMed ID: 32358791
    [No Abstract]   [Full Text] [Related]  

  • 20. Cutaneous manifestation of COVID-19 in images: a case report.
    Avellana Moreno R; Estela Villa LM; Avellana Moreno V; Estela Villa C; Moreno Aparicio MA; Avellana Fontanella JA
    J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):e307-e309. PubMed ID: 32330339
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.